SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-23-303575
Filing Date
2023-12-27
Accepted
2023-12-27 09:41:25
Documents
1
Effectiveness Date
2023-12-27

Document Format Files

Seq Description Document Type Size
1 S-8 POS d685129ds8pos.htm S-8 POS 19196
  Complete submission text file 0001193125-23-303575.txt   20312
Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957
POINT Biopharma Global Inc. (Filer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-266812 | Film No.: 231515038
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)